Labcorp loses US Fed Circuit appeal over Ravgen DNA sampling patent
The US Court of Appeals for the Federal Circuit ruled against the Laboratory Corporation of America on Monday, affirming that a DNA sampling patent held by Ravgen should not be canceled...To view the full article, register now.
Already a subscriber? Click here to view full article